脂質ナノディスクにおけるM2マスカリン受容体-βアレスティン複合体の構造
Dean P Staus1,2, Hongli Hu3,4, Michael J Robertson3,5
1Department of Medicine, Duke University Medical Center, Durham, NC, USA.
Nature
|January 17, 2020
まとめ
研究者らは,βアレスティン1 (βarr1) が,Gタンパク質結合受容体 (GPCRs) と,冷凍EMを用いてどのように相互作用するかを明らかにした. 受容体と脂質二層を含むこの相互作用は,受容体内化とシグナルの無敏感化にとって鍵となる.
科学分野:
- 構造生物学
- セルラー信号
- バイオ物理学
背景:
- Gタンパク質結合受容体 (GPCRs) はシグナル伝達経路を活性化し,β-アレスティンを無感化および内細胞化に利用する.
- G- タンパク質の相互作用とは異なり,β - アレスティンのGPCRとの相互作用の分子機構は十分に理解されていない.
研究 の 目的:
- M2マスカリン受容体 (M2R) とのβアレスティン1 (βarr1) 相互作用の構造的基礎を解明する.
- 細胞反応におけるレセプターと脂質二層の両方とのβarr1の相互作用の役割を理解する.
主な方法:
- ナノディスクにおけるM2R-βarr1複合体の構造を決定するための冷凍電子顕微鏡 (冷凍EM).
- 機能的役割を検証するために,原子模擬,生体物理,生化学,および細胞検査を行います.
主要な成果:
- 凍結EM構造は,N領域結合と指のループ挿入を含むβarr1とM2Rの多様相互作用ネットワークを明らかにした.
- 複合体の安定性と機能にとって重要な相互作用である.
- この相互作用はβarr1の徴募,受容体の内部化,Gタンパク質の無敏感化に不可欠である.
結論:
- β - アレスティン1は,GPCRと脂質二層の両方と多用途の相互作用ネットワークを使用します.
- 受容体と膜との協力結合は,β-アレスティンの多様なシグナル伝達役割とGPCR活性調節に不可欠である.
関連する概念動画
Fluid Mosaic Model
15.4K
Scientists identified the plasma membrane in the 1890s and its principal chemical components (lipids and proteins) by 1915. The model for plasma membrane structure, proposed in 1935 by Hugh Davson and James Danielli, was the first model to be widely accepted in the scientific community. The model was based on the plasma membrane's "railroad track" appearance in early electron micrographs. Davson and Danielli theorized that the plasma membrane's structure resembled a sandwich...
15.4K
Assembly of Signaling Complexes
6.4K
Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
6.4K
Cholinergic Receptors: Muscarinic
4.5K
The pharmacological actions of acetylcholine are elicited via its binding to two families of cholinergic receptors or cholinoceptors, namely, muscarinic and nicotinic receptors. Muscarinic receptors are G protein-coupled receptors and have five subtypes, M1–M5. All mAChR subtypes are activated by acetylcholine and blocked by the antagonist, atropine.
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+....
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+....
4.5K
Cholinergic Receptors: Nicotinic
5.1K
Nicotinic receptors are ligand-gated ion channels that are activated by acetylcholine and nicotine. Upon activation, they cause a rapid increase in the permeability of cells to K+, Na+, and Ca2+, followed by depolarization and excitation. They are in the autonomic ganglia, skeletal neuromuscular junction, CNS, and adrenal medulla.
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
5.1K


